Advocacy intelligence hub — real-time data for patient organizations
GLYCOPYRROLATE: New indication approved
Cuvposa: FDA approved
To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Neurometabolic disorder due to serine deficiency news →
View all Neurometabolic disorder due to serine deficiency specialists →